SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Job Trends
Valeant’s New U.S. Headquarters Will House Up To 500 Staffers
November 14, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Zoetis May Be Valeant’s Plan B
November 13, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Beach
Valeant Woos Influential Doctors In Anticipation Of A Takeover
November 13, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Valeant: We Will Bump Allergan Inc. Offer To $200 A Share
October 27, 2014
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Valeant Hints At Higher Bid For Allergan Inc.
October 21, 2014
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Policy
Lawyers Have Documents That Prove Allergan Inc. Misled Investors About Valeant: Ackman
October 17, 2014
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Will Sweeten Allergan Inc. Bid To Clinch Deal
October 8, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
FDA Slaps Valeant With A Warning Letter
October 1, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
BioMidwest
If Allergan Inc. Survives Valeant, AbbVie, Shire or Actavis/Forest May Be Suitors
September 30, 2014
 · 
2 min read
Load More
IN THE PRESS
Business
Valeant Renews CeraVe Partnership With USA Swimming As Exclusive Skincare Sponsor
September 16, 2015
 · 
3 min read
Drug Development
Valeant And Progenics Pharmaceuticals, Inc. Announce FDA Acceptance Of NDA Submission For Oral RELISTOR
September 8, 2015
 · 
5 min read
Business
Valeant Announces The Addition Of D. Robert Hale To Its Board Of Directors
August 25, 2015
 · 
4 min read
Deals
Commonweath Laboratories Announces Agreement With Valeant For The Acquisition Of Commonwealth’s U.S. And Canadian Business
July 23, 2015
 · 
4 min read
Business
Valeant Reports Second Quarter 2015 Financial Results
July 23, 2015
 · 
5 min read
Deals
Valeant Spree Continues With $28 Million Buy
July 13, 2015
 · 
2 min read
Business
EyeGate Pharma Signs Licensing Agreement With Valeant For EGP-437 Combination Product In Uveitis
July 10, 2015
 · 
3 min read
Business
Valeant To Announce 2015 Second Quarter Results On July 23, 2015
June 24, 2015
 · 
1 min read
Policy
Valeant and Progenics Pharmaceuticals, Inc. Announce the Submission of U.S. New Drug Application for Oral RELISTOR
June 23, 2015
 · 
5 min read
FDA
Valeant Release: RELISTOR Receives European Approval For Expanded Indication To Treat All Opioid-Induced Constipation
June 3, 2015
 · 
7 min read
Load More